RAC 2.30% $1.49 race oncology ltd

Q. Bisantrene is not new. How can RAC monetise if it is out of patent?, page-119

  1. 953 Posts.
    lightbulb Created with Sketch. 236
    If you look, you’ll see he was looking out for retail and existing holders from day one of his involvement, when he cornerstoned the cr (at premium to sp) that kept the company afloat.
    Last edited by cas33VFL: 09/07/24
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.